Home / Intelligence / Case Studies / Improving Targeting Precision and Field Force Direction through AIML-based Patient Finding
Background
- A global rare disease company was looking to improve targeting precision and support field team effectiveness
- Traditional targeting was non-viable due to the small size of the patient populations, complex disease recognition and diagnosis, and restrictive therapy eligibility criteria
- Attempts by a prior analytics partner to use rule-based alerts failed, and even after two years, no new patients had been identified
- Given the small number of patients in each indication, every new start is high value, both for the lives of patients in need and for the commercial success of the therapies
Trinity’s Solution
- Create an AIML model that identifies clinically on-label patients—rather than simply patients with the disease
- ‘Learn’ from on-therapy patients to identify how patients present prior to therapy initiation and execute AIML models to flag patients based on the probability that they are candidates for treatment
- Deploy bifurcated notifications to both inside and field-based reps through ‘push’ alerts within the client’s CRM and enable ‘pull’ solutions to support call planning
- Success drivers include:
- Data acumen to evaluate and select source data
- Therapeutic area expertise
- Deep collaboration with Medical to refine and calibrate models
- AIML experience to optimize feature selection and approach
Project Outcomes

Designed and deployed AIML models for three indications in 8 weeks

Narrowed field team focus from >25,000 HCPs to ~1,000 highest priority HCPs

Identified 100 high probability targets within first 2 months of launch

At least 5 patients confirmed to be clinically on-label for therapy within first 2 months

First new patient enrolled within 5 weeks of initiating alerts
If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.
Related Intelligence
Case Studies
Optimizing HCP Call Planning with a Best‑in‑Class AIML Engine
The Situation Mid-Size Pharma, High-Potential HCP Identification Trinity’s Solution A digitally-integrated, AI-enabled ecosystem powering rep effectiveness and personalized HCP engagement Trinity AI assessed the client’s technology ecosystem and existing targeting engine to scope the context and needs for a more efficient solution. Trinity redesigned an AI-driven call plan engine to identify high-potential HCP targets in […]
Read More
Webinars
The GenAI Advantage: Empowering Pharma Customer-Facing Teams
Available On Demand
Join us for the first webinar in our “AI Innovations in Life Sciences” series to learn how generative AI (GenAI) can transform the way customer-facing teams (sales reps and medical science liaisons) operate in life sciences companies. Discover practical applications of GenAI to enhance call planning and customer engagement and help field teams translate data […]
Watch Now
White Papers
Technology with a Point of View: Encoding Life Sciences Expertise with AI
Discover how Trinity Life Sciences is transforming pharma commercialization with generative AI (GenAI). In this white paper, experts share how Trinity’s GenAI-powered solutions are reshaping Medical Affairs, Field Insights, Competitive Intelligence and more—delivering faster insights, reducing friction and unlocking new value across the organization. What You’ll Learn: Download the Full White Paper Fill out the […]
Read More